Bankwala Z, Hale S L, Kloner R A
University of Southern California, Los Angeles.
Circulation. 1994 Aug;90(2):1023-8. doi: 10.1161/01.cir.90.2.1023.
Brief episodes of ischemia induced by proximal coronary artery occlusion can precondition the myocardium. Whether other stressful stimuli have the potential to protect the myocardium from subsequent ischemia remains controversial.
To study the hypothesis that transient alpha-adrenoceptor stimulation mimics preconditioning, for 5 minutes we administered 0.25 micrograms.kg-1.min-1 norepinephrine or saline 10 minutes before a 30-minute coronary occlusion and 4 hours of reperfusion in an in vivo rabbit model. The area of necrosis (AN) and area of risk (AR) were measured. We found that norepinephrine pretreatment caused a reduction in infarct size when compared with controls (AN/AR, 0.17 +/- 0.04 versus 0.31 +/- 0.04; P < .02). Ischemic preconditioning also reduced infarct size (AN/AR, 0.22 +/- 0.03). The protection observed with norepinephrine treatment was entirely eliminated by pretreatment with alpha-adrenergic blockade using prazosin (AN/AR, 0.42 +/- 0.06). Tyramine, an agent that causes release of endogenous catecholamines, was administered (1.5 mg/kg i.v.) 10 minutes before coronary occlusion in another group of rabbits. Tyramine pretreatment resulted in a smaller infarct size than in untreated controls (AN/AR, 0.16 +/- 0.04 versus 0.41 +/- 0.07; P < .01). Both norepinephrine and tyramine caused an increase in systemic arterial pressure during infusion; tyramine also increased heart rate. In rabbits pretreated with prazosin, heart rate and systemic pressure during the norepinephrine infusion were similar to baseline values. During coronary occlusion, the degree of ischemia was similar in all groups.
Exposure of the heart to either transient exogenous norepinephrine or endogenous release of norepinephrine and/or other catecholamines by tyramine can mimic the effects of ischemic preconditioning in rabbits.
近端冠状动脉闭塞诱导的短暂缺血发作可使心肌产生预处理效应。其他应激刺激是否具有保护心肌免受后续缺血影响的潜力仍存在争议。
为研究短暂性α-肾上腺素能受体刺激模拟预处理这一假说,在体内兔模型中,于30分钟冠状动脉闭塞和4小时再灌注前10分钟,我们以0.25微克·千克⁻¹·分钟⁻¹的剂量静脉输注去甲肾上腺素或生理盐水,持续5分钟。测量坏死面积(AN)和危险面积(AR)。我们发现,与对照组相比,去甲肾上腺素预处理可使梗死面积减小(AN/AR,0.17±0.04对0.31±0.04;P<0.02)。缺血预处理也可减小梗死面积(AN/AR,0.22±0.03)。使用哌唑嗪进行α-肾上腺素能阻滞预处理可完全消除去甲肾上腺素治疗所观察到的保护作用(AN/AR,0.42±0.06)。在另一组兔子中,于冠状动脉闭塞前10分钟静脉注射酪胺(1.5毫克/千克),酪胺是一种可引起内源性儿茶酚胺释放的药物。酪胺预处理导致的梗死面积小于未治疗的对照组(AN/AR,0.16±0.04对0.41±0.07;P<0.01)。输注过程中,去甲肾上腺素和酪胺均可使体动脉压升高;酪胺还可使心率加快。在用哌唑嗪预处理的兔子中,去甲肾上腺素输注期间的心率和体动脉压与基线值相似。冠状动脉闭塞期间,所有组的缺血程度相似。
心脏暴露于短暂的外源性去甲肾上腺素或酪胺引起的内源性去甲肾上腺素和/或其他儿茶酚胺释放,均可模拟兔缺血预处理的效应。